PH clinical trials in LATAM

Presented at PVRI 2026 Congress by Tomas Pulido, Ignacio Chavez National Heart Institute

Summary

Clinical studies in Latin America face challenges such as the underrepresentation of Hispanic populations and access to medications. There is a need for collaboration in research to address genetic differences and improve patient access. Adapting clinical trials to local contexts is crucial, along with considering environmental factors and ensuring timely diagnosis. Coordinated efforts across Latin American countries are essential to enhance research capabilities and patient care.

Generated by AI, edited by PVRI